Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Kanghui Holdings Prices IPO, Rises in Trading

publication date: Aug 11, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Kanghui Holdings, a China orthopedic device maker, priced its IPO in the exact middle of its expected range, $10.25 per ADS, raising a total of $68.4 million in the offering. The pricing showed investors took a favorable read on Kanghui’s business, an interest also shown in subsequent open market trading. Kanghui’s ADSs rose 88 cents to $11.13, a 9% increase, in early NYSE action. More details....

Stock Symbol: (NYSE: KH)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...